Milford, Mass.
Biomeasure, a subsidiary of French pharmaceutical company Ipsen, is initiating a $45 million expansion and renovation of its campus in Milford, Mass. Ground will be broken in mid-2012 on a three-story, 62,000-sf facility housing R&D and process science labs. Two existing buildings at the site, a research facility and a cGMP manufacturing plant totaling 77,000 sf, will be extensively renovated. Completion is expected in early 2014. Additionally, the company's headquarters will be relocated from Brisbane, Calif., to a 30,000-sf facility in Bridgewater, N.J.
